What's driving the Global Transcriptomics Market Growth? Prominent Players: QIAGEN, Thermo Fisher Scientific, Illumina, Agilent Technologies, GE Healthcare Dharmacon, Bio-Rad Laboratories, Bio-Rad Laboratories, Merck, Fluidigm Corporation

Rising demand for personalized medicines is a key factor driving the global transcriptomics market, says Fortune Business Insights in a report, titled "Transcriptomics Market Size, Share and Global Trend By Technology (Polymerase Chain Reaction (PCR), Microarray, Next-Generation Sequencing (NGS)), By Application (Drug Discovery, Clinical Diagnostics, Toxicogenomics), By End-User (Academic and Research Institutes, Pharmaceutical Companies, Biotechnology Companies) and Geography Forecast till 2026." Rapid innovations and improvements in healthcare infrastructure is expected to aid the growth of the global transcriptomics market.

Get Sample Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/transcriptomics-market-101227

According to the report, the increasing demand for transcriptomics due to its DNA microarrays and next-generation sequencing technologies has impelled new companies to enter the market. This factor will encourage the growth of the global transcriptomics market. For instance, in April 2017, Seven Bridges, a biomedical data analysis company announced a financial investment in Spatial Transcriptomics AB, a life science start-up, which is developing innovative technology to analyze tissue samples in two dimensions.

The report provides a comprehensive overview of the transcriptomics industry. It offers insights into factors enablibg growth in the global transcriptomics market. The study focuses on the recent product launches and acquisitions by leading market players.

Increasing R&D Investments Will Propel Growth

The rapid adoption of transcriptomics and increasing demand for personalized medicine is expected to boost the global transcriptomics market revenue during the forecast period. Further, the launch of MI Transcriptome, an advanced gene profiling product is expected to stimulate the growth of the global transcriptomics market. For instance, Caris Life Sciences launched an advanced gene profiling product, MI Transcriptome which enables Whole Transcriptome Sequencing (WTS). The newly developed technology has the capability to provide in detail RNA sequencing analysis. In addition, growing number of biopharmaceutical companies and rising expenditure on research and development is predicted to further enable the growth of the global transcriptomics market.

Launch Of CORALL Will Favor Growth

Lexogen, a transcriptomics company focused on the development of innovative kits and software for RNA-Seq, launched CORALL-Total RNA-Seq Library Prep Kit. The new kit will be utilized in transcriptome analysis. Moreover,the acquisition of Spatial Transcriptomics by 10x Genomics is expected to uplift the global transcriptomics market shares during the forecast period. For instance, 10x Genomics acquired Spatial Transcriptomics, a potential player in spatial genomics. Nonetheless, lack of skilled professionals in emerging nations is likely to restrict the global transcriptomics market growth during the forecast period.

Rising Prevalence Of Chronic Disorders Will Enable Growth In North America

Geographically, the global transcriptomics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global transcriptomics market owing to the rising demand for personalized medicines and growing cases of chronic disorders such as cancer and others. In addition, rising investment in the research and development of transcriptomics technologies will further accelerate growth in North America. Asia Pacific is expected to grow at a significant CAGR during the forecast period due to the increasing number of pharmaceutical and biotechnology companies in the region. Moreover, high demand for transcriptomics technologies and increasing investments in R&D and drug development will further boost growth in Asia Pacific.

Some of the major companies operating in the global transcriptomics market are:

o��������� QIAGEN

o��������� Thermo Fisher Scientific Inc.

o��������� Illumina, Inc.

o��������� Agilent Technologies

o��������� GE Healthcare Dharmacon Inc.

o��������� Bio-Rad Laboratories, Inc.

o��������� F. Hoffmann-La Roche Ltd.

o��������� Merck & Co., Inc.

o��������� Fluidigm Corporation

o��������� Promega Corporation

Browse complete Report: https://www.fortunebusinessinsights.com/industry-reports/transcriptomics-market-101227

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Pune Banglore Highway Pashan Exit, Baner, Pune, Maharashtra 411045, India

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

This release was published on openPR.